Accumetrics,
Inc.
|
|
Accumetrics,
Inc. Forms Partnership with Grifols as Its Distributor in
Spain, Portugal and Chile
Accumetrics, Inc. Announces
GRAVITAS Trial 50 Percent Enrolled
Accumetrics,
Inc. Announces Distribution Channels in Israel and Cyprus
back to top |
Alereon, Inc. |
|
Ultrawideband: Down, But Far From Out
WiMedia and UWB: where to from here?
Alereon Receives FCC Modular Certification for Worldwide
Wireless USB Half-MiniCard
back to top |
Apollo Endosurgery,
Inc. |
|
Three
Austin Companies Get Cancer Research Grants
Most
Successful U.S. Startups 2008: Apollo Endosurgery -
BusinessWeek
Apollo Endosurgery Announces 510(k) Clearance for its
Flexible Endoscopic Suturing System
Surgery Without the Slicing
back to top |
| Asuragen,
Inc. |
|
Asuragen's
Ground Breaking Research Funded with Help from Grants
Program
Asuragen
Appoints French Distributor Biomedical Diagnostics SA for
Signature Oncology Portfolio
Mirna
Therapeutics Announces Dr. Frank Slack as Scientific Advisor
Gov. Perry Announces $5
Million Investment in Development, Commercialization of
Cancer Treatment
back to top
|
| BioForm
Medical, Inc. (NASDAQ: BFRM) |
|
Merz to Acquire BioForm Medical
BioForm Medical Strengthens Its Board of Directors With
Three Aesthetics Industry Veterans
BioForm Medical to Launch New 1.5cc RADIESSE(r) Volume
Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe;
Announces Successful Results of RADIESSE Dermal Filler With
Lidocaine Clinical Study
back to top
|
| BioMimetic
Pharmaceuticals, Inc. ("BMTI") (NASDAQ: BMTI) |
BioMimetic nears European
patent on tissue healing products
Dr. Samuel E. Lynch Presides Over the NASDAQ
Closing Bell to Celebrate
the Initial Public Offering of BioMimetic Therapeutics, Inc. [BMTI]
back
to top |
| BioSurface
Engineering
Technologies,
Inc. ("BioSET") |
|
Brookhaven Lab and BioSET, Inc., Patent a Synthetic Peptide
That Enhances Bone Growth
BioSET Announces Initiation Of Clinical Trials For AMPLEX
Osteo-Promotive Bone Graft System For Spine Fusion
Tornier and Bioset Enter Synthetic Growth Factor Pact
back
to top
|
| Cameron Health, Inc. |
|
Entirely Subcutaneous ICD Eliminates Need For Transvenous Lead Wires
The rhythm of life
Cameron Health Commences Clinical Trial of the Minimally
Invasive Totally Subcutaneous Implantable Defibrillator for
Treatment of Sudden Cardiac Arrest
back
to top |
| Cardiva Medical, Inc. |
| Cardiva
Medical, Inc. Announces Appointment of Charles Maroney,
President and Chief Executive Officer
Cardiva Medical, Inc. Receives FDA Clearance for the
Catalyst III System
Cardiva Medical, Inc. Announces Presentation at the 2008 UBS
Global Life Science Conference
back
to top
|
| GlycoMimetics,
Inc. ("GMI") |
|
GlycoMimetics, Inc. Attracts $38
Million in Latest Venture Round
New Drug to
Treat Sickle Cell Crisis Begins Pilot Study in Patients
GlycoMimetics, Inc. Awarded NIH Grant to Study Drug
Candidate in Diabetes
GlycoMimetics, Inc. Completes Phase 1 Clinical Studies
of Lead Drug Candidate
back to top |
| IDEV
Technologies, Inc. |
|
IDEV
Technologies
Names Veteran Healthcare Executive Dennis Donohoe, M.D.
Chief Medical Officer
IDEV
Technologies Introduces SUPERA VERITAS™ Stent
Delivery System in Europe
IDEV
Technologies Names Christopher M. Owens President, Chief
Executive Officer
IDEV
Technologies Announces First Patient Enrolled in
Multi-Center Clinical Trial of SUPERA Peripheral Stent
back to top |
| InSite
Vision, Inc. ("ISV") (INSV.OB) |
|
InSite Vision Signs International Licensing and Distribution
Agreement for AzaSite((R)) in Japan and Taiwan With Nitten
Pharmaceutical Co., Ltd
InSite Vision Receives Regulatory Approval for AzaSite® in
Canada
InSite Vision Announces Restructuring to Support 2009
Strategic Priorities
back to top |
|
Intersect ENT, Inc. (formerly Sinexus) |
Sinexus Changes Name to Intersect ENT, Initiates Pivotal
Study
back
to top
|
| LDR
Spine USA, Inc. ("LDR") |
|
1st Mobi-C® cervical artificial disc implanted in China
LDR Announces FDA Clearance of its ROI-A™ ALIF Device
LDR opens direct sales channel in Germany
back
to top
|
| Mirna
Therpeutics, Inc. |
|
Mirna
Therapeutics recommended for $10 million commercialization
award from the Cancer Prevention and Research Institute of
Texas
back
to top |
| On-X® Life Technologies, Inc. |
|
On-X Life Technologies Doubles Manufacturing Space in Austin
Examination of
hemolytic potential with the On-X(R) prosthetic heart valve
Austin-Based Medical Carbon Research Institute, LLC. Becomes On-X Life
Technologies, Inc.
back
to top |
| Ortho
Kinematics, Inc. |
|
Kinegraph
VMA™ (Vertebral Motion Analyzer) Video
Gov. Perry: We Must Invest Wisely to Help Texans and
Strengthen Our Economy
back
to top
|
| OsteoBiologics,
Inc. ("OBI")
- Acquired by: Smith & Nephew |
Smith &
Nephew Acquires OBI, Inc.
back
to top |
| Tryton Medical, Inc. |
|
TRYTON Announces Registry
Evaluating Tryton Stent System for Left Main Disease and
Celebrates 500th Implant
Tryton
Celebrates 250th Implant of Innovative Side Branch Stent
System
Tryton
Announces First Patient Enrollment in E-Tryton 150 Registry
Tryton Medical introduces Side Branch Stent System in Europe
back
to top
|
| ZIOPHARM Oncology, Inc. (NASDAQ:
ZIOP) |
|
ZIOPHARM Presents Positive
Darinaparsin Clinical Data at ASCO's Prestigious Clinical
Science Symposium
ZIOPHARM Presents Positive
Data from Phase I Study of Palifosfamide in Combination with
Doxorubicin at ASCO
ZIOPHARM
Presents Positive Indibulin Translationaland Dose Scheduling
Data at ASCO
back
to top |
| |
| |
| |
|
